Lung Cancer Vaccine Gets Injection of Funding for R&D

Source link :

Development of a DNA-based lung cancer vaccine in the United Kingdom received funding for 2 years of laboratory research and initial manufacture of 3000 doses, according to a press release from the University of Oxford, Oxford, England. A team of scientists from the University of Oxford, the Francis Crick Institute, and University College London (UCL) […]

Author : News Health

Publish date : 2024-04-02 05:34:18

Copyright for syndicated content belongs to the linked Source.